Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001493152-22-019505

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ng Carey Director 2022-07-14 Grant or award · Stock Options +16,000 16,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…